We are live on ! Find out more
MDGL icon

Madrigal Pharmaceuticals

97 hedge funds and large institutions have $148M invested in Madrigal Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 38 increasing their positions, 24 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

58% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 24

46% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 13

7% more funds holding

Funds holding: 9197 (+6)

4% more capital invested

Capital invested by funds: $143M → $148M (+$5.59M)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

31% less call options, than puts

Call options by funds: $695K | Put options by funds: $1.01M

Holders
97
Holders Change
+6
Holders Change %
+6.59%
% of All Funds
2.61%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
19
Increased
38
Reduced
24
Closed
13
Calls
$695K
Puts
$1.01M
Net Calls
-$314K
Net Calls Change
+$11K
Name Holding Trade Value Shares
Change
Change in
Stake
BBA
101
Baker Bros. Advisors
New York
-$949K -13,973 Closed
SM
102
Sabby Management
Florida
-$794K -11,400 Closed
Tudor Investment Corp
103
Tudor Investment Corp
Connecticut
-$388K -5,714 Closed
BACM
104
Blue Arrow Capital Management
New York
-$388K -5,712 Closed
GL
105
GLG LLC
New York
-$97K -1,429 Closed
GCP
106
GSA Capital Partners
United Kingdom
-$61K -894 Closed
PP
107
Paloma Partners
Connecticut
-$37K -551 Closed
TSS
108
Two Sigma Securities
New York
-$23K -335 Closed
TRCT
109
Tower Research Capital (TRC)
New York
-$12K -185 Closed
ST
110
Spot Trading
Illinois
+$504 +6 New